interim

Interim Report January September 2025

Interim Report January  –  September 2025 Third Quarter 2025 (compared to third quarter 2024) Net sales for the quarter amounted…

6 days ago

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025

November 18, 2025 16:30 ET  | Source: Protara Therapeutics NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.…

2 weeks ago

Sonata Software Consolidated PAT grew by 10% QoQ, Declares second interim dividend of 1.25 per share

MUMBAI, India, Nov. 13, 2025 /PRNewswire/ -- Sonata Software (NSE: SONATSOFTW) (BSE: 532221), a leading Modernization Engineering Company, today reported…

3 weeks ago

NTG Nordic Transport Group publishes interim report for Q3 2025

Company announcement no. 10 – 25 10 November 2025 NTG Nordic Transport Group publishes interim report for Q3 2025 The…

4 weeks ago

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

October 24, 2025 11:39 ET  | Source: PMV Pharmaceuticals, Inc. Data presented today as an oral presentation at 2025 AACR-NCI-EORTC…

1 month ago

Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine

October 14, 2025 08:05 ET  | Source: Candel Therapeutics NEEDHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc.…

2 months ago

Appointment of Marc Le Bozec as Interim CEO

Appointment of Marc Le Bozec as Interim CEO Nantes, October 3, 2025, 8:00 a.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173;…

2 months ago

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…

3 months ago

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

September 11, 2025 17:01 ET  | Source: Achieve Life Sciences SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE)…

3 months ago

Shanghai Electric Reports Growth in Both Revenue and Profit in 2025 Interim Report

SHANGHAI, Sept. 9, 2025 /PRNewswire/ -- Shanghai Electric (SEHK: 2727, SSE: 601727), a global leader in industrial and energy equipment…

3 months ago